223514-59-8

Basic information

• Product Name: (S)-N-(4-methoxycarbonylphenylethyl)acetamide
• Synonyms: (S)-N-(4-methoxycarbonylphenylethyl)acetamide
• CAS NO: 223514-59-8
• Molecular Weight: 221.256
• Mol File: 223514-59-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (S)-N-(4-methoxycarbonylphenylethyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-N-(4-methoxycarbonylphenylethyl)acetamide(223514-59-8)
• EPA Substance Registry System: (S)-N-(4-methoxycarbonylphenylethyl)acetamide(223514-59-8)

Safety Data

• Hazardous Substances Data: 223514-59-8(Hazardous Substances Data)

Usage

Description

(S)-N-(4-methoxycarbonylphenylethyl)acetamide, a chemical compound with the molecular formula C12H15NO3, is a derivative of acetamide featuring a phenylethyl group with a methoxycarbonyl substituent. This white to off-white powder is utilized in pharmaceutical research, primarily as an intermediate in the synthesis of various pharmaceuticals. Its potential therapeutic effects are attributed to possible interactions with receptors and enzymes in the body, which warrant further investigation to elucidate its pharmacological properties and applications.

Uses

Used in Pharmaceutical Research:
(S)-N-(4-methoxycarbonylphenylethyl)acetamide is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of novel medications.
Used in Medical Treatments:
(S)-N-(4-methoxycarbonylphenylethyl)acetamide is being studied for its potential application in the treatment of medical conditions such as pain and inflammation, due to its possible interactions with receptors and enzymes in the body.
Further research is necessary to fully understand the compound's pharmacological properties, therapeutic effects, and potential applications in various industries.

Upstream product

• 2627-86-3 (S)-1-phenyl-ethylamine 
• 147169-48-0 (S)-tert-butyl 1-phenylethylcarbamate 
• 1169867-32-6 methyl 4-(1-acetylaminovinyl)benzoate 
• 88146-41-2 N-[(1S)-1-(4-acetylphenyl)ethyl]acetamide 
• 67-56-1 methanol 
• 19144-86-6 (S)-N-acetyl-1-phenylethylamine 

Downstream Products

• 223514-63-4 (S)-N-(1-(4-chloromethylphenyl)ethyl)acetamide 
• 1196047-13-8 methyl (S)-4-(1-acetamidoethyl)-3-fluorobenzoate 
• 1196047-06-9 methyl (S)-4-(1-acetamidoethyl)-3-chlorobenzoate 
• 1196047-03-6 methyl (S)-3-amino-4-(1-acetamidoethyl)benzoate 
• 1196047-02-5 methyl (S)-4-(1-acetamidoethyl)-3-nitro benzoate 
• 1196047-10-5 (S)-4-(1-aminoethyl)-3-chlorobenzoic acid hydrochloride 
• 223514-61-2 (S)-N-(1-(4-hydroxymethylphenyl)ethyl)acetamide 

Relevant articles and documents

Preparation method of optically pure 4-(1-amino) ethyl benzoate and salt thereof

The invention relates to a preparation method of of optically pure 4-(1-amino) ethyl benzoate and salt thereof. The method has the characteristics of low cost, environmental friendliness, high opticalpurity, simplicity and convenience in operation and easiness in industrial production.

Piperazine compounds and medicinal use thereof

The present invention relates to a piperazine compound of the formula wherein R1and R2are each hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, nitro, hydroxy or cyano, R3, R4and R5are each hydrogen, halogen, lower alkyl, lower alkoxy, nitro, amino, substituted amino or hydroxy, R6and R7are each hydrogen, lower alkyl, lower alkyl substituted by halogen, aralkyl, acyl or lower acyl substituted by halogen, R8and R9are each hydrogen or lower alkyl, Y is lower alkylene and the like, and ring A is phenyl, pyrimidyl, thiazolyl, pyridyl, pyrazyl or imidazolyl, a pharmaceutically acceptable salt thereof and pharmaceutical agents containing these compounds. The compound of the present invention has superior TNF-α production inhibitory effect and/or IL-10 production promoting effect, and, since it is free of or shows only strikingly reduced expression of an effect on the central nervous system, the compound is useful as a highly safe and superior TNF-α production inhibitor an/or IL-10 production promoter and is useful as an agent for the prophylaxis or treatment of various diseases caused by abnormal TNF-α production, diseases curable with IL-10, such as chronic inflammatory diseases, acute inflammatory diseases, inflammatory diseases due to infection, autoimmune diseases, allergic diseases, and TNF-α mediated diseases.